These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28752643)

  • 1. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
    Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
    Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
    Staines KA; Hopkinson M; Dillon S; Stephen LA; Fleming R; Sophocleous A; Buttle DJ; Pitsillides AA; Farquharson C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover.
    Sophocleous A; Idris AI; Ralston SH
    Calcif Tissue Int; 2014 Mar; 94(3):259-68. PubMed ID: 24036631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
    Idris AI; van 't Hof RJ; Greig IR; Ridge SA; Baker D; Ross RA; Ralston SH
    Nat Med; 2005 Jul; 11(7):774-9. PubMed ID: 15908955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
    Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
    Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral cannabinoid receptor, CB2, regulates bone mass.
    Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.
    Simkins T; Crawford RB; Goudreau JL; Lookingland KJ; Kaplan BL
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):544-57. PubMed ID: 24870806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice.
    Wang F; Wang PX; Wu XL; Dang SY; Chen Y; Ni YY; Gao LH; Lu SY; Kuang Y; Huang L; Fei J; Wang ZG; Pang XF
    PLoS One; 2013; 8(7):e68497. PubMed ID: 23844209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.
    Nakamura H; Aoki K; Masuda W; Alles N; Nagano K; Fukushima H; Osawa K; Yasuda H; Nakamura I; Mikuni-Takagaki Y; Ohya K; Maki K; Jimi E
    J Bone Miner Res; 2013 Jun; 28(6):1457-67. PubMed ID: 23322687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.
    Khedgikar V; Kushwaha P; Gautam J; Verma A; Changkija B; Kumar A; Sharma S; Nagar GK; Singh D; Trivedi PK; Sangwan NS; Mishra PR; Trivedi R
    Cell Death Dis; 2013 Aug; 4(8):e778. PubMed ID: 23969857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
    Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
    Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice Missing Cnr1 and Cnr2 Show Implantation Defects.
    Li Y; Bian F; Sun X; Dey SK
    Endocrinology; 2019 Apr; 160(4):938-946. PubMed ID: 30776303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.
    Sophocleous A; Landao-Bassonga E; Van't Hof RJ; Idris AI; Ralston SH
    Endocrinology; 2011 Jun; 152(6):2141-9. PubMed ID: 21447627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1(-/-)) mice.
    Khalid AB; Goodyear SR; Ross RA; Aspden RM
    Med Eng Phys; 2016 Oct; 38(10):1044-54. PubMed ID: 27401043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
    Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
    Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor type 2 gene is associated with human osteoporosis.
    Karsak M; Cohen-Solal M; Freudenberg J; Ostertag A; Morieux C; Kornak U; Essig J; Erxlebe E; Bab I; Kubisch C; de Vernejoul MC; Zimmer A
    Hum Mol Genet; 2005 Nov; 14(22):3389-96. PubMed ID: 16204352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
    Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
    FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss.
    Dobson PF; Dennis EP; Hipps D; Reeve A; Laude A; Bradshaw C; Stamp C; Smith A; Deehan DJ; Turnbull DM; Greaves LC
    Sci Rep; 2020 Jul; 10(1):11643. PubMed ID: 32669663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.